120 related articles for article (PubMed ID: 2693750)
1. Application of thrombin-antithrombin III complex for detecting a latent hypercoagulable state in patients with coronary artery disease.
Uno M; Tsuji H; Watanabe M; Takada O; Kobayashi K; Takabuchi H; Shirai K; Sawada S; Toyoda T; Yamamoto K
Jpn Circ J; 1989 Oct; 53(10):1185-91. PubMed ID: 2693750
[TBL] [Abstract][Full Text] [Related]
2. Use of enzyme-linked immunosorbent assay to measure thrombin-antithrombin III complexes in horses with colic.
Topper MJ; Prasse KW
Am J Vet Res; 1996 Apr; 57(4):456-62. PubMed ID: 8712506
[TBL] [Abstract][Full Text] [Related]
3. Prothrombin fragments F1+2, thrombin-antithrombin III complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis.
Giannitsis E; Siemens HJ; Mitusch R; Tettenborn I; Wiegand U; Schmücker G; Sheikhzadeh A; Stierle U
Int J Cardiol; 1999 Mar; 68(3):269-74. PubMed ID: 10213277
[TBL] [Abstract][Full Text] [Related]
4. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
5. [Molecular marker for detecting hypercoagulable state].
Magari Y; Mizunaga S; Ito M; Shibata T; Ito H
Rinsho Byori; 1994 Jan; 42(1):22-33. PubMed ID: 8107279
[TBL] [Abstract][Full Text] [Related]
6. [The thrombin-antithrombin III complex ELISA test in diagnosis of surgery-induced blood coagulation activation].
Kemen M; Sperling H; Mumme A; Zumtobel V
Infusionstherapie; 1991 Aug; 18(4):199-201. PubMed ID: 1937844
[TBL] [Abstract][Full Text] [Related]
7. Enzyme-linked immunosorbent assay for thrombin-antithrombin III complexes in horses.
Topper MJ; Prasse KW; Morris MJ; Duncan A; Crowe NA
Am J Vet Res; 1996 Apr; 57(4):427-31. PubMed ID: 8712502
[TBL] [Abstract][Full Text] [Related]
8. High F1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA.
Garcia-Avello A; Garcia-Frade LJ; Gandarias C; Ocaña J; Cancelas JA; Lasso M
Thromb Res; 1994 Jan; 73(2):109-15. PubMed ID: 8171409
[TBL] [Abstract][Full Text] [Related]
9. [D-dimer, thrombin-antithrombin III-complex (TAT) and prothrombin fragment 1+2 (PTF). Parameters for monitoring therapy with low molecular-weight heparin in coagulation disorders].
Hofmann M; Rest A; Hafner G; Tanner B; Brockerhoff P; Weilemann LS
Anaesthesist; 1997 Aug; 46(8):689-96. PubMed ID: 9382207
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic antithrombin III administration during pregnancy immediately reduces the thrombin hyperactivity of congenital antithrombin III deficiency by forming thrombin-antithrombin III complexes.
Kario K; Matsuo T; Kodama K; Matsuo M
Thromb Res; 1992 Jun; 66(5):509-15. PubMed ID: 1523607
[TBL] [Abstract][Full Text] [Related]
11. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
[TBL] [Abstract][Full Text] [Related]
12. [Thrombin, antithrombin, thrombin-antithrombin complex (TAT)].
Sakata T
Nihon Rinsho; 2004 Dec; 62 Suppl 12():626-8. PubMed ID: 15658407
[No Abstract] [Full Text] [Related]
13. [Thrombin markers in pregnant women: measurements of prothrombin fragments F 1+2 and thrombin-antithrombin III complexes (TAT) in the cord blood, the mother's blood and in amniotic fluid].
Uszyński W; Uszyński M; Zekanowska E
Ginekol Pol; 2004 Aug; 75(8):595-602. PubMed ID: 15517782
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the coagulation and fibrinolytic systems in men with intermittent claudication.
Handa K; Takao M; Nomoto J; Oku K; Shirai K; Saku K; Arakawa K
Angiology; 1996 Jun; 47(6):543-8. PubMed ID: 8678328
[TBL] [Abstract][Full Text] [Related]
15. Increased plasminogen activator inhibitor antigen levels in diabetic patients with stable angina.
Daví G; Violi F; Catalano I; Giammarresi C; Putignano E; Nicolosi G; Barbagallo M; Notarbartolo A
Blood Coagul Fibrinolysis; 1991 Feb; 2(1):41-5. PubMed ID: 1772997
[TBL] [Abstract][Full Text] [Related]
16. Thrombin-antithrombin III complexes as an additional diagnostic aid in pulmonary embolism.
Carmassi F; Morale M; de Negri F; Puccetti R; Pistelli F; Mariani G; Pazzagli M; Palla A; Giuntini C
Haemostasis; 1996; 26(1):16-22. PubMed ID: 8698274
[TBL] [Abstract][Full Text] [Related]
17. Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer.
Gabazza E; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
Cancer; 1993 Oct; 72(7):2134-40. PubMed ID: 7690680
[TBL] [Abstract][Full Text] [Related]
18. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S
Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184
[TBL] [Abstract][Full Text] [Related]
19. Hypercoagulability and chronic atrial fibrillation: the role of markers of thrombin generation.
Soncini M; Casazza F; Mattioli R; Bonfardeci C; Motta A; Cimminiello C
Minerva Med; 1997 Dec; 88(12):501-5. PubMed ID: 9540779
[TBL] [Abstract][Full Text] [Related]
20. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K
Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
